8-K: Datavault AI Secures $12M, Amends Notes & Warrants

Datavault AI Inc. announced a $12 million registered direct offering of convertible notes, an exchange of warrants for common stock, and amendments to prior notes, all subject to stockholder approval.

Summary

• Datavault AI Inc. entered into a Securities Purchase Agreement on August 4, 2025, for a registered direct offering of senior secured convertible notes.
• The offering includes Initial Notes with an aggregate principal amount of $6,666,666 for a purchase price of $6,000,000, and Additional Notes with the same principal and purchase amounts, totaling $13,333,332 in principal for $12,000,000.
• The Notes are convertible into common stock at an initial conversion price of $1.00 per share, or an alternate conversion price equal to the greater of a $0.1019 floor price and 80% of the lowest volume-weighted average price (VWAP) over 20 trading days.
• The company also entered into Exchange Agreements on August 4, 2025, to exchange approximately 31 million common stock purchase warrants for an equal number of common shares.
• Prior senior secured convertible notes issued on April 3, 2025, and May 21, 2025, will be amended to revise their alternate conversion price formula, changing from 90% of the lowest VWAP over 10 days to 80% of the lowest VWAP over 20 days, while retaining their original floor price.
• Stockholder approval for these issuances was obtained via written consent on August 4, 2025, from holders representing approximately 52% of the company's voting power, approving the issuance of up to 130,847,236 shares related to the Notes.
• A definitive information statement on Schedule 14C will be mailed to stockholders, and the actions will become effective no earlier than 20 calendar days after its mailing.

Sentiment

Score: 3

Explanation: The filing indicates a necessary capital raise and capital structure adjustments, but the terms (significant dilution, discount on notes, and VWAP-based conversion) suggest a challenging financial position and are generally unfavorable for existing shareholders. While securing funding is positive, the cost of that funding is high.

Positives

• Secured $12,000,000 in new capital through a registered direct offering, providing funding for operations or strategic initiatives.
• Obtained stockholder approval via written consent from holders representing approximately 52% of voting power, indicating strong insider support for the capital raise and warrant exchange.
• The exchange of warrants for common stock simplifies the capital structure by converting potential future dilution into immediate common stock, potentially reducing overhang.

Negatives

• The convertible notes and warrant exchange will result in significant dilution for existing shareholders, with up to 130,847,236 shares potentially issued from the notes alone, plus 31 million from warrant exchange.
• The alternate conversion price for the new notes and amended prior notes allows conversion at 80% of the lowest VWAP over 20 trading days (subject to a floor), which could lead to further dilution if the stock price declines.
• The purchase price for the notes ($12,000,000) is at a discount to the aggregate principal amount ($13,333,332), implying a discount for the investors.

Risks

• Significant dilution risk for existing shareholders due to the issuance of common stock upon conversion of the Notes (up to 130,847,236 shares) and the exchange of warrants (approximately 31 million shares).
• Potential for further dilution if the stock price drops, as the alternate conversion price for the notes is tied to 80% of the lowest VWAP over 20 trading days, subject to a floor price of $0.1019.
• The effectiveness of the Additional Closing and the warrant exchange is contingent on the mailing of a definitive information statement on Schedule 14C and the subsequent 20-calendar-day waiting period, introducing a time-based contingency.
• The company's ability to satisfy customary closing conditions for the Initial Notes and additional closing conditions for the Additional Notes.

Future Outlook

The company anticipates completing the Initial Closing upon satisfaction of customary conditions and the Additional Closing after a 20-calendar-day waiting period following the mailing of a definitive information statement on Schedule 14C, which will describe the stockholder-approved actions.

Management Comments

• Datavault AI Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Industry Context

This filing indicates a common strategy for smaller, publicly traded companies to raise capital through convertible debt, often at a discount, and to restructure existing liabilities (warrants, prior notes) to manage their capital structure and comply with listing rules. The use of a registered direct offering suggests a need for capital without a full public offering, often appealing to institutional investors willing to accept convertible terms. The amendment of prior notes and the warrant exchange are typical actions to clean up or optimize the balance sheet and reduce future uncertainty related to conversion terms.

Comparison to Industry Standards

• The use of senior secured convertible notes is a common financing instrument for growth-stage technology companies, similar to those used by companies like Palantir Technologies (PLTR) in earlier stages or various biotech firms seeking capital for R&D.
• The conversion price mechanism, including a floor price and a discount to VWAP (80% of lowest VWAP over 20 days), is a standard feature in such convertible debt instruments, designed to provide downside protection for investors while allowing for equity participation. For example, similar structures have been observed in financings for companies like MicroStrategy (MSTR) when issuing convertible notes, though their scale and specific terms differ.
• The exchange of warrants for common stock is a capital structure optimization move, often seen in companies like Plug Power (PLUG) or Nikola (NKLA) that have previously issued warrants and seek to simplify their cap table or reduce the dilutive overhang of outstanding warrants.
• Obtaining stockholder approval via written consent for Nasdaq Listing Rule 5635(d) compliance is a standard regulatory requirement for transactions involving significant equity issuance, ensuring transparency and adherence to exchange rules, comparable to actions taken by many small-cap companies on Nasdaq.

Corporate Governance

Stakeholder Impact

• Shareholders: Significant dilution due to the issuance of new common stock from convertible notes and warrant exchange. Potential for further dilution if the stock price declines due to VWAP-based conversion terms.
• Investors (Purchasers): Gain senior secured convertible notes at a discount, with favorable conversion terms (initial $1.00, or 80% of lowest VWAP with a $0.1019 floor), providing potential for significant equity upside.
• Warrant Holders: Exchange existing warrants for immediate common stock, simplifying their position and removing the need for future exercise.

Next Steps

• Initial Closing of the Initial Notes, subject to customary closing conditions.
• Mailing of a definitive information statement on Schedule 14C to stockholders.
• Additional Closing of the Additional Notes, subject to additional closing conditions, on or after 20 calendar days following the mailing of the Schedule 14C information statement.
• Effectiveness of actions approved in the Written Consent (including warrant exchange and note amendments) no earlier than 20 calendar days following the mailing of the Information Statement.
• Company expected to enter into agreements with Purchasers to amend Prior Notes at the Initial Closing.

Key Dates

Recommendation

The filing details a highly dilutive capital raise and restructuring of existing liabilities. The terms of the convertible notes, including a significant discount on principal and a conversion price tied to 80% of the lowest VWAP over 20 days (subject to a low floor), indicate a distressed financing. The issuance of up to 130 million shares from the notes, plus 31 million from warrant exchange, will substantially increase the share count, likely putting significant downward pressure on the stock price. While the company secures funding, the cost to existing shareholders is very high, suggesting a 'sell' recommendation due to impending dilution and unfavorable financing terms.

Keywords

Datavault AI, DVLT, SEC Filing, 8-K, Convertible Notes, Registered Direct Offering, Warrant Exchange, Stockholder Approval, Capital Raise, Dilution, Nasdaq Listing Rule 5635(d), Senior Secured Notes, Corporate Finance